Prostate-Specific Antigen Bounce After High-Dose-Rate Monotherapy for Prostate Cancer

2013 ◽  
Vol 86 (4) ◽  
pp. 729-733 ◽  
Author(s):  
Niraj H. Mehta ◽  
Mitchell Kamrava ◽  
Pin-Chieh Wang ◽  
Michael Steinberg ◽  
Jeffrey Demanes
Keyword(s):  
Prostate Cancer ◽  
Dose Rate ◽  
Prostate Specific Antigen ◽  
Specific Antigen ◽  
High Dose Rate ◽  
High Dose

Prostate-specific antigen bounce after external beam radiotherapy plus high-dose-rate brachytherapy boost for definitive management of localized prostate cancer

Brachytherapy ◽  
2009 ◽  
Vol 8 (2) ◽  
pp. 178-179
Author(s):  
Anuj V. Peddada ◽  
Scott B. Jenings ◽  
Patrick O. Faricy ◽  
Richard A. Walsh III ◽  
Gregory L. Gibbs ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Dose Rate ◽  
Prostate Specific Antigen ◽  
External Beam Radiotherapy ◽  
Specific Antigen ◽  
High Dose Rate ◽  
High Dose ◽  
External Beam ◽  
Brachytherapy Boost ◽  
Definitive Management

scholarly journals Salvage high dose-rate brachytherapy for local recurrence of prostate cancer after different types of radical treatment

2019 ◽  
Vol 15 (2) ◽  
pp. 73-76
Author(s):  
V. A. Solodkiy ◽  
A. Yu. Pavlov ◽  
A. D. Tsybulskiy ◽  
A. G. Dzidzariya ◽  
A. S. Pchelintsev
Keyword(s):  
Prostate Cancer ◽  
Dose Rate ◽  
Specific Antigen ◽  
Cancer Recurrence ◽  
High Dose Rate ◽  
High Dose ◽  
High Dose Rate Brachytherapy ◽  
Prostate Cancer Recurrence ◽  
Background Therapy

Objective: at the primary analysis of prostate cancer treatment referring to the patients who have experienced high dose rate brachytherapy after a confirmed locally recurrent tumor having been treated with diverse treatment modes.Materials and methods. The research includes 28 patients aged 53 to 78 years old (average age is 66 years old) with histologically verified prostate cancer recurrence. Within the period 2015–2017 all the patients got a salvage high dose rate brachytherapy in the Russian Scientific Center of Roentgenradiology. Brachytherapy was carried out as 2 fractions with the single tumor dose of 12.5 Gy. There was a two-week gap between fractions with the total tumor dose of 25 Gy. The follow-up period is 9 to 36 months.Results and conclusion. Overall biochemical free survival rate is 82.1 %. There are 5 people having a growing prostatic specific antigen (PSA) while the case follow-up. There is 1 case of a confirmed local tumor recurrence. Significant factors of the disease progression after salvage brachytherapy are: risk group, pretreatment PSA high, time line from the background therapy to biochemical recurrence uprise and PSA level if there’s prostate cancer recurrence after the background therapy.

Prostate-specific antigen bounce after high-dose-rate prostate brachytherapy and hypofractionated external beam radiotherapy

Brachytherapy ◽  
2014 ◽  
Vol 13 (5) ◽  
pp. 450-455 ◽  
Author(s):  
Nita Patel ◽  
Luis Souhami ◽  
Jose João Mansure ◽  
Marie Duclos ◽  
Armen Aprikian ◽  
...  
Keyword(s):  
Dose Rate ◽  
Prostate Specific Antigen ◽  
External Beam Radiotherapy ◽  
Specific Antigen ◽  
High Dose Rate ◽  
High Dose ◽  
Prostate Brachytherapy ◽  
External Beam
Sign in / Sign up

Export Citation Format

Share Document